248 related articles for article (PubMed ID: 23402264)
1. Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNA.
Shao W; Boltz VF; Spindler JE; Kearney MF; Maldarelli F; Mellors JW; Stewart C; Volfovsky N; Levitsky A; Stephens RM; Coffin JM
Retrovirology; 2013 Feb; 10():18. PubMed ID: 23402264
[TBL] [Abstract][Full Text] [Related]
2. Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA.
Boltz VF; Rausch J; Shao W; Hattori J; Luke B; Maldarelli F; Mellors JW; Kearney MF; Coffin JM
Retrovirology; 2016 Dec; 13(1):87. PubMed ID: 27998286
[TBL] [Abstract][Full Text] [Related]
3. Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies.
Zagordi O; Klein R; Däumer M; Beerenwinkel N
Nucleic Acids Res; 2010 Nov; 38(21):7400-9. PubMed ID: 20671025
[TBL] [Abstract][Full Text] [Related]
4. Concordance between allele-specific PCR and ultra-deep pyrosequencing for the detection of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations.
Hunt GM; Morris L; Moorthy A; Coovadia A; Abrams EJ; Strehlau R; Kuhn L; Persaud D
J Virol Methods; 2014 Oct; 207():182-7. PubMed ID: 25034127
[TBL] [Abstract][Full Text] [Related]
5. Next-generation sequencing of HIV-1 RNA genomes: determination of error rates and minimizing artificial recombination.
Di Giallonardo F; Zagordi O; Duport Y; Leemann C; Joos B; Künzli-Gontarczyk M; Bruggmann R; Beerenwinkel N; Günthard HF; Metzner KJ
PLoS One; 2013; 8(9):e74249. PubMed ID: 24058534
[TBL] [Abstract][Full Text] [Related]
6. An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.
Simen BB; Braverman MS; Abbate I; Aerssens J; Bidet Y; Bouchez O; Gabriel C; Izopet J; Kessler HH; Stelzl E; Di Giallonardo F; Schlapbach R; Radonic A; Paredes R; Recordon-Pinson P; Sakwa J; St John EP; Schmitz-Agheguian GG; Metzner KJ; Däumer MP;
J Virol Methods; 2014 Aug; 204():31-7. PubMed ID: 24731928
[TBL] [Abstract][Full Text] [Related]
7. HIV drug resistance surveillance using pooled pyrosequencing.
Ji H; Massé N; Tyler S; Liang B; Li Y; Merks H; Graham M; Sandstrom P; Brooks J
PLoS One; 2010 Feb; 5(2):e9263. PubMed ID: 20174661
[TBL] [Abstract][Full Text] [Related]
8. Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next-Generation Sequencing of HIV-1 Genomic RNA Populations.
Zhou S; Jones C; Mieczkowski P; Swanstrom R
J Virol; 2015 Aug; 89(16):8540-55. PubMed ID: 26041299
[TBL] [Abstract][Full Text] [Related]
9. Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain.
Keys JR; Zhou S; Anderson JA; Eron JJ; Rackoff LA; Jabara C; Swanstrom R
AIDS Res Hum Retroviruses; 2015 Jun; 31(6):658-68. PubMed ID: 25748056
[TBL] [Abstract][Full Text] [Related]
10. Inclusion of full length human immunodeficiency virus type 1 (HIV-1) gag sequences in viral recombinants applied to drug susceptibility phenotyping.
Robinson LH; Gale CV; Kleim JP
J Virol Methods; 2002 Jul; 104(2):147-60. PubMed ID: 12088824
[TBL] [Abstract][Full Text] [Related]
11. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.
Palmer S; Kearney M; Maldarelli F; Halvas EK; Bixby CJ; Bazmi H; Rock D; Falloon J; Davey RT; Dewar RL; Metcalf JA; Hammer S; Mellors JW; Coffin JM
J Clin Microbiol; 2005 Jan; 43(1):406-13. PubMed ID: 15635002
[TBL] [Abstract][Full Text] [Related]
12. Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.
Kapoor A; Jones M; Shafer RW; Rhee SY; Kazanjian P; Delwart EL
J Virol; 2004 Jul; 78(13):7112-23. PubMed ID: 15194787
[TBL] [Abstract][Full Text] [Related]
13. PCR-induced transitions are the major source of error in cleaned ultra-deep pyrosequencing data.
Brodin J; Mild M; Hedskog C; Sherwood E; Leitner T; Andersson B; Albert J
PLoS One; 2013; 8(7):e70388. PubMed ID: 23894647
[TBL] [Abstract][Full Text] [Related]
14. PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA.
Fang G; Weiser B; Visosky A; Moran T; Burger H
Nat Med; 1999 Feb; 5(2):239-42. PubMed ID: 9930876
[TBL] [Abstract][Full Text] [Related]
15. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
[TBL] [Abstract][Full Text] [Related]
16. Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance.
Galli RA; Sattha B; Wynhoven B; O'Shaughnessy MV; Harrigan PR
J Clin Microbiol; 2003 Jul; 41(7):2900-7. PubMed ID: 12843019
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing.
Hedskog C; Mild M; Jernberg J; Sherwood E; Bratt G; Leitner T; Lundeberg J; Andersson B; Albert J
PLoS One; 2010 Jul; 5(7):e11345. PubMed ID: 20628644
[TBL] [Abstract][Full Text] [Related]
18. MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing.
Huber M; Metzner KJ; Geissberger FD; Shah C; Leemann C; Klimkait T; Böni J; Trkola A; Zagordi O
J Virol Methods; 2017 Feb; 240():7-13. PubMed ID: 27867045
[TBL] [Abstract][Full Text] [Related]
19. Indel and Carryforward Correction (ICC): a new analysis approach for processing 454 pyrosequencing data.
Deng W; Maust BS; Westfall DH; Chen L; Zhao H; Larsen BB; Iyer S; Liu Y; Mullins JI
Bioinformatics; 2013 Oct; 29(19):2402-9. PubMed ID: 23900188
[TBL] [Abstract][Full Text] [Related]
20. HIV type-1 drug resistance in treatment-naive patients monitored using minority species assays: a systematic review and meta-analysis.
Buckton AJ; Harris RJ; Pillay D; Cane PA
Antivir Ther; 2011; 16(1):9-16. PubMed ID: 21311104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
